Can a wrinkle treatment calm a rare, painful skin disease?

NCT ID NCT02782702

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 21, 2026 ยท Last updated Sep 21, 2026

Summary

Hailey-Hailey and Darier disease are rare inherited skin conditions that cause painful, itchy lesions in skin folds. Sweating makes them worse, and standard treatments often do not work well. Researchers are testing whether botulinum toxin injections into large skin folds can reduce sweating and improve patients' quality of life. The trial enrolls 30 adults with moderate to severe lesions and measures changes in a skin-related quality-of-life score over six months.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
botulinum toxin injections into large skin folds
What this could lead to
If it helps, botulinum toxin injections could become a way to ease the painful, itchy skin lesions these rare conditions cause, especially in hot weather when sweating makes them worse.
What could go wrong
This is a small early-stage trial of 30 people, so any benefit may not hold up in larger studies. Botulinum toxin can cause weakness, trouble swallowing, or allergic reactions in some people.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 1

The first testing in people. Mainly checks safety and dose, usually in a small group.

Participants

30 people

The number who actually took part.

Start date

Sep 2015

Finished

Nov 2017

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Confirmed diagnosis (clinical and histological features) of Hailey Hailey or Darier diseases. * Moderate to very severe lesions located in large folds * Patient aged 18 ans or more * Patient with health coverage * Patient who have signed the consent form * Patient proficient into filling out the questionnaires. Exclusion Criteria: * Hypersensibility to toxin or excipients * Myastheny * Deglutition's problems * Past medical history of dysphagia or aspiration pneumonia * Pregnancy (positive B-HCG test performed a maxima 72h before) or breastfeeding * Mental , physical incapacity to fill in the questionnaires * Guardianship patients * Skin infections at the inclusion visit * Application in the last 7 days at the site of injection of local treatments (apart emollients or antiseptics) or injections of botulism toxin or dynamic phototherapy or laser in the last 6 months. * Systemic treatment with aminosides in the last 15 days * Inclusion in another study in the last 2 months.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Darier disease are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Centre Hospitalier Universitaire

    Toulouse, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.